IL-33, sST2, and CRP in Panic Disorder

Recruiting Observational Study
Panic Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 65
Sex
Any
Study type
Observational
Participants needed
80 (estimated)
Sponsor
Elazığ Mental Health and Diseases Hospital · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Panic disorder (PD) is characterized by recurrent and unexpected panic attacks and is associated with significant functional impairment. Increasing evidence suggests involvement of immune-inflammatory mechanisms in PD. Elevated levels of inflammatory markers such as C-reactive protein (CRP) have been reported in PD; however, interleukin-33 (IL-33) and soluble suppressor tumorogenicity-2 (sST2), co…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
1. For Panic Disorder (PD) Group: \*Inclusion Criteria: * Being between 18-65 years of age * Having a diagnosis of panic disorder (PD) according to DSM-5-TR and having presented to the hospital with panic attack symptoms of the disorder * Not having previously used any medication for ps…
Contacts

Mehmet Hamdi ÖRÜM, MD, Ass. Prof., Psychiatrist

+905382207558

mhorum@hotmail.com

CONTACT